Catalog name Description price
R-M2-10000 DMG-PEG-FAM DMG-PEG2K-FAM is mainly used for fluorescent labeling and tracing of nanocarriers. The PEG segment provides a surface barrier effect, which can reduce the non-specific adsorption of nanoparticles in organisms, while the FAM group can be used to track the distribution, metabolism, and targeting processes of nanoparticles in real time. In biomedical research, such materials are commonly used to construct multifunctional delivery systems, such as combining fluorescent labeling with targeted functions for visual drug delivery and efficacy evaluation. price>
R-M1-8385 C18-PEG-TPP C18-PEG2K-TPP,C18-PEG2K-Triphenyl phosphate is a kind of heterogeneous and bifunctional peg reagent.TPP has low volatility,transparency,softness, toughness,plasticization,flame retardancy and excellent light stability. price>
R-M2-10027 Se-Se-PEG-PSMA-617 The design of Se-Se-PEG-PSMA-617 may aim to utilize the redox sensitivity of selenium selenium bonds to achieve controlled release or activation of drugs in specific environments, such as the tumor microenvironment. This type of molecule may be used for: Prodrug design: Local activation of PSMA-617 is achieved by breaking the Se Se bond, improving the treatment window. Responsive delivery: Combining PSMA targeting with redox responsiveness to achieve tumor specific drug release. price>
R-M2-10028 Se-Se-PEG-PSMA-11 Se–Se–PEG–PSMA-11 is a PEGylated prostate-specific membrane antigen (PSMA) targeting ligand in which the PSMA-11 moiety is connected to polyethylene glycol (PEG) via a diselenide (Se–Se) linker. Typical Applications: PSMA-targeted nanoparticles or drug delivery systems; Redox-responsive theranostic platforms; Ligand conjugation for prostate cancer imaging (PET/SPECT/optical); Surface modification of liposomes, polymeric NPs, or inorganic NPs. price>
R-M2-10029 Se-Se-PEG-PSMA-ligand-1 Se–Se–PEG–PSMA-ligand-1 is a PEG-modified prostate-specific membrane antigen (PSMA) targeting ligand engineered with a diselenide (Se–Se) redox-cleavable linker. This design combines selective PSMA receptor binding with controlled, tumor-microenvironment-responsive behavior. Applications: Functionalization of liposomes, polymeric nanoparticles, inorganic nanocarriers; Targeted drug-delivery or theranostic systems for prostate cancer; Construction of stimuli-responsive PSMA-targeting conjugates; Redox-cleavable linkers in nanomedicine, bioconjugation, and radiopharmaceuticals. price>
R-M1-8440 Rhein-PEG2K-TPP Rhein-PEG2K-TPP is a composite molecule that combines the therapeutic potential of rhein with the benefits of a PEG linker and the mitochondria-targeting ability of the TPP cation. This composite may hold promise in mitochondrial drug delivery systems or other biomedical applications targeting mitochondria-related conditions. price>
R-MC-001 C18-PEG2k-NOTA By combining the C18 alkyl group, PEG2k linker, and NOTA chelating agent, C18-PEG2k-NOTA can have potential applications in various fields, such as the development of targeted drug delivery systems, imaging agents, or radiopharmaceuticals. The compounds amphiphilic nature, hydrophobicity, and metal chelation properties make it a versatile candidate for designing functional materials in drug discovery, medical diagnostics, or molecular imaging. price>
R-M1-8471 DMG-PEG-Streptavidin DMG-PEG-Streptavidin is a versatile tool in molecular biology research, enabling the specific detection and purification of biotinylated molecules. price>
R-M1-8490 DMG-PEG-RB DMG-PEG-RB,1,2-Dimyristoyl-sn-glycerol-methoxypolyethylene glycol-Rhodamine B from ruixibio.The combination of DMG, PEG, and RB in DMG-PEG-RB for specific applications such as enhanced cellular uptake or targeted delivery of a bioactive molecule. The PEG2000 component may contribute to improved solubility, while the RB component can enable fluorescence-based visualization or tracking of the delivered molecule. price>
R-M1-8506 Heparin-PEG-PBA Heparin-PEG-PBA,heparin-PEG-Phenylboronic acid is a conjugated molecule that combines the anticoagulant properties of heparin with the sugar-binding capabilities of phenylboronic acid, expanding its potential applications in the field of biomedical research and therapeutics. price>